Article and Study Summary: Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial Published in: Lancet. 2022;399(10337):1779-1789 https://doi.org/10.1016/S0140-6736(22)00538-4 Authors: Delany-Moretlwe S, Hughes...
Article and Study Summary: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis Published in: New England Journal of Medicine 2022;386(12):1109-1120 https://www.nejm.org/doi/full/10.1056/NEJMoa2111904 Authors: Jarvis JN, Lawrence DS, Meya DB, et...
Article and Study Summary: Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children Published in: New England Journal of Medicine 2022;386(10):911-922. https://www.nejm.org/doi/full/10.1056/NEJMoa2104535 Authors: Turkova A, Wills GH, Wobudeya E, et...
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...
Article and Study Summary: Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis. Published in: New England Journal of Medicine. 2021;385(26):2441-2450 https://www.nejm.org/doi/full/10.1056/NEJMoa2105470 Authors: Cattamanchi A, Reza TF,...
